首页> 外文OA文献 >Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients

【2h】

Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients

机译：人源化抗CD25单克隆抗体治疗类固醇耐火急性接枝 - 宿主病：中国64名患者中的中国单中心经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
T Tao; X Ma; J Yang; J-Y Zou; S-M Ji; Y-S Tan; W Gong; F Du; J Xu; C-M Ye; X-W Tang; D-P Wu; S-L Xue;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients [J] . T Tao, X Ma, J Yang, Blood cancer journal. . 2015,第4期

机译：人源化抗CD25单克隆抗体治疗类固醇难治性急性移植物抗宿主病：64名患者的中国单中心经验
2. Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody [J] . Chakupurakal Geothy, Garcia-Marquez Maria Alejandra, Shimabukuro-Vornhagen Alexander, European Journal of Haematology . 2016,第2期

机译：CD25单克隆抗体巴利西单抗治疗后对类固醇难治性移植物抗宿主病患者的免疫学影响
3. A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease. [J] . Carpenter PA, Lowder J, Johnston L, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2005,第6期

机译：人源化抗CD3抗体Visilizumab的II期多中心研究，用于治疗类固醇难治性急性移植物抗宿主病。
4. The prevalence of Takotsubo cardiomyopathy among patients with acute coronary syndrome in single-center experience [C] . Fijalkowski M., Koprowski A., Jaguszewski M., International Congress on Coronary Artery Disease . 2009

机译：单中心经验中急性冠状动脉综合征患者Takotsubo心肌病的患病率
5. The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease [D] . Srinagesh, Hrishikesh Krishna. 2020

机译：魔术算法概率（地图）是急性接枝腹膜疾病治疗的验证响应生物标志物
6. Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients [O] . T Tao, X Ma, J Yang, 2015

机译：人源化抗CD25单克隆抗体治疗类固醇难治性急性移植物抗宿主病：64名患者的中国单中心经验
7. A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease [O] . Carpenter Paul A., Lowder James, Johnston Laura, 2005

机译：人源化抗CD3抗体Visilizumab的II期多中心研究，用于治疗类固醇难治性急性移植物抗宿主病
8. Humanized Monoclonal Antibody Specific to the Extracellular Domain of PSMA: Dose Escalation Trial in Patients with Prostate Cancer [R] . Vallabhajosula, S. 2003

机译：psma细胞外区特异性人源化单克隆抗体：前列腺癌患者的剂量递增试验

Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients

著录项

引文网络

相似文献

相关主题

期刊订阅